Catherine Coste

Insider Reports History

Location
Danville, CA
Signature
/s/ Catherine Coste
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Coste:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOLIFE SOLUTIONS INC Director Common Stock 5.7K $145K $25.44 18 Mar 2025 Direct
BIOMERICA INC Director Common stock 129K $39.9K $0.31 13 Dec 2024 Direct
MINERVA SURGICAL INC Director Common Stock 130K $26.5K $0.20 10 Jun 2022 Direct
Renalytix plc Director Employee Stock Option (right to buy) 95K 20 Nov 2023 Direct

Insider Reports Filed by Catherine Coste

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BLFS BIOLIFE SOLUTIONS INC 18 Mar 2025 1 $0 4 Director 20 Mar 2025, 19:09
BLFS BIOLIFE SOLUTIONS INC 18 Mar 2025 0 $0 3 Director 20 Mar 2025, 19:08
BMRA BIOMERICA INC 13 Dec 2024 1 $26.4K 4 Director 17 Dec 2024, 19:30
BMRA BIOMERICA INC 13 Dec 2023 1 $0 4 Director 14 Dec 2023, 17:10
BMRA BIOMERICA INC 07 Dec 2023 1 $0 4 Director 11 Dec 2023, 17:18
RNLX Renalytix plc 20 Nov 2023 1 $0 4 Director 22 Nov 2023, 16:29
RNLX Renalytix plc 06 Jul 2023 1 $0 4 Director 07 Jul 2023, 16:28
RNLX Renalytix plc 01 Jul 2023 0 $0 3 Director 03 Jul 2023, 16:19
BMRA BIOMERICA INC 26 Jan 2023 1 $6.48K 4 Director, Audit Committee Chairperson 30 Jan 2023, 10:36
UTRS MINERVA SURGICAL INC 10 Jun 2022 1 $120K 4 Director 14 Jun 2022, 13:05
BMRA BIOMERICA INC 09 Dec 2021 1 $0 4 Director 10 Dec 2021, 16:18
UTRS MINERVA SURGICAL INC 21 Oct 2021 0 $0 3 Director 21 Oct 2021, 19:27